BEGIN:VCALENDAR VERSION:2.0 PRODID:-//swoogo.com//NONSGML kigkonsult.se iCalcreator 2.41.90// CALSCALE:GREGORIAN UID:33656163-3332-4764-b737-383631373234 BEGIN:VEVENT UID:90917b40aa95ce3a2672bb74116d3bca663b0985@swoogo.com DTSTAMP:20261008T005813Z DESCRIPTION:This session presents a critical overview of deformational plag iocephaly-brachycephaly (DPB) in infants\, with a focus on the recent incr ease in incidence\, risk factors\, treatment options\, the impact of insur ance coverage on treatment access\, and implications for federal health ag encies and their beneficiaries. First\, key distinctions among the differe nt cranial shapes\, including plagiocephaly\, brachycephaly\, scaphocephal y\, and craniosynostosis will be outlined\, as well as a thorough review o f the risk factors associated with DPB\, including congenital muscular tor ticollis\, intrauterine constraint\, supine sleeping positions\, and prema turity. Second\, the unintended consequences of the “Back to Sleep” campai gn\, which aimed to reduce sudden infant death syndrome (SIDS) and how thi s contributed to a sharp increase in incidence of DPB\, will be presented. Third\, a brief review of cranial anatomy and the mechanism behind head g rowth will provide insight into the development of these deformities and w ill underscore the necessity of timely intervention. Fourth\, preventative strategies\, including repositioning\, neck exercises\, and tummy time\, will be reviewed alongside treatment options like cranial remolding orthos es (CROs)\, which capture and redirect growth to return the head to its na tural configuration. Fifth\, an exploration of the advancements in the reg ulatory clearance for CROs and evidence-based protocols for care will be h ighlighted\, with an emphasis on the rapidly expanding body of literature. Lastly\, the impact of insurance coverage on treatment access will be exp lored by comparing commercial insurance with state and federal programs\, emphasizing how insurance disparities can critically influence treatment d uration and outcomes. Concluding with a call to action\, this presentation aims to highlight the importance of early recognition and intervention\, equipping participants with tools to foster better health outcomes and inc reased access to care in this population. DTSTART:20250304T213000Z DTEND:20250304T223000Z LAST-MODIFIED:20261008T005813Z LOCATION: SEQUENCE:0 STATUS:CONFIRMED SUMMARY:Abnormal Head Shape (Deformational Plagiocephaly-Brachycephaly) in Infants: Established Protocols for Care and Current Coverage Policy Review TRANSP:OPAQUE X-ALT-DESC;FMTTYPE=text/html:

This session presents a critical overview o f deformational plagiocephaly-brachycephaly (DPB) in infants\, with a focu s on the recent increase in incidence\, risk factors\, treatment options\, the impact of insurance coverage on treatment access\, and implications f or federal health agencies and their beneficiaries. First\, key distinctio ns among the different cranial shapes\, including plagiocephaly\, brachyce phaly\, scaphocephaly\, and craniosynostosis will be outlined\, as well as a thorough review of the risk factors associated with DPB\, including con genital muscular torticollis\, intrauterine constraint\, supine sleeping p ositions\, and prematurity. Second\, the unintended consequences of the “B ack to Sleep” campaign\, which aimed to reduce sudden infant death syndrom e (SIDS) and how this contributed to a sharp increase in incidence of DPB\ , will be presented. Third\, a brief review of cranial anatomy and the mec hanism behind head growth will provide insight into the development of the se deformities and will underscore the necessity of timely intervention. F ourth\, preventative strategies\, including repositioning\, neck exercises \, and tummy time\, will be reviewed alongside treatment options like cran ial remolding orthoses (CROs)\, which capture and redirect growth to retur n the head to its natural configuration. Fifth\, an exploration of the adv ancements in the regulatory clearance for CROs and evidence-based protocol s for care will be highlighted\, with an emphasis on the rapidly expanding body of literature. Lastly\, the impact of insurance coverage on treatmen t access will be explored by comparing commercial insurance with state and federal programs\, emphasizing how insurance disparities can critically i nfluence treatment duration and outcomes. Concluding with a call to action \, this presentation aims to highlight the importance of early recognition and intervention\, equipping participants with tools to foster better hea lth outcomes and increased access to care in this population.

BEGIN:VALARM UID:62386665-3130-4332-b261-613363633239 ACTION:DISPLAY DESCRIPTION:This session presents a critical overview of deformational plag iocephaly-brachycephaly (DPB) in infants\, with a focus on the recent incr ease in incidence\, risk factors\, treatment options\, the impact of insur ance coverage on treatment access\, and implications for federal health ag encies and their beneficiaries. First\, key distinctions among the differe nt cranial shapes\, including plagiocephaly\, brachycephaly\, scaphocephal y\, and craniosynostosis will be outlined\, as well as a thorough review o f the risk factors associated with DPB\, including congenital muscular tor ticollis\, intrauterine constraint\, supine sleeping positions\, and prema turity. Second\, the unintended consequences of the “Back to Sleep” campai gn\, which aimed to reduce sudden infant death syndrome (SIDS) and how thi s contributed to a sharp increase in incidence of DPB\, will be presented. Third\, a brief review of cranial anatomy and the mechanism behind head g rowth will provide insight into the development of these deformities and w ill underscore the necessity of timely intervention. Fourth\, preventative strategies\, including repositioning\, neck exercises\, and tummy time\, will be reviewed alongside treatment options like cranial remolding orthos es (CROs)\, which capture and redirect growth to return the head to its na tural configuration. Fifth\, an exploration of the advancements in the reg ulatory clearance for CROs and evidence-based protocols for care will be h ighlighted\, with an emphasis on the rapidly expanding body of literature. Lastly\, the impact of insurance coverage on treatment access will be exp lored by comparing commercial insurance with state and federal programs\, emphasizing how insurance disparities can critically influence treatment d uration and outcomes. Concluding with a call to action\, this presentation aims to highlight the importance of early recognition and intervention\, equipping participants with tools to foster better health outcomes and inc reased access to care in this population. TRIGGER:-PT15M END:VALARM END:VEVENT END:VCALENDAR